Related Experiment Video
Updated: Apr 22, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
9.2K
Immunotherapy for non-small cell lung cancer
1Department of Internal Medicine, Chosun University School of Medicine, Gwangju, Korea.
Tuberculosis and Respiratory Diseases
|October 14, 2014
Summary
Lung cancer immunotherapy shows promise for advanced non-small cell lung cancer (NSCLC). Further clinical trials are needed to establish its role in treating this deadly disease.
Area of Science:
- Oncology
- Immunology
Background:
- Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality globally, with over 80% of cases.
- Current treatments like chemotherapy and targeted therapy have limitations for advanced NSCLC.
- Novel therapeutic strategies are crucial for improving patient outcomes.
Purpose of the Study:
- To explore the potential of immunotherapy as a novel treatment for advanced non-small cell lung cancer (NSCLC).
- To review promising immunotherapeutic approaches, including immune checkpoint inhibition and cancer vaccination.
- To highlight the need for clinical trials to establish immunotherapy's role in NSCLC treatment.
Main Methods:
- Review of current literature on lung cancer treatment and immunotherapy.
- Analysis of immunotherapeutic strategies such as immune checkpoint inhibitors and cancer vaccines.
- Discussion of the immunological mechanisms underlying immunotherapy in cancer.
Main Results:
- Immunotherapy aims to enhance the immune system's recognition and response to cancer cells.
- Immune checkpoint inhibition and cancer vaccination are promising immunotherapeutic approaches for NSCLC.
- Immunotherapy currently lacks an established role in NSCLC treatment.
Conclusions:
- Immunotherapy offers a potential new avenue for treating advanced non-small cell lung cancer.
- Further research and clinical trials are essential to validate and optimize immunotherapy for NSCLC.
- Patients with advanced NSCLC are encouraged to participate in clinical trials investigating immunotherapies.
More Related Videos
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.7K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.1K
Related Concept Videos
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
02:57Targeted Cancer Therapies
6.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
6.9K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:49Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K